Probiotec Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Probiotec Limited with three other
pharmaceutical manufacturers in Australasia:
Vita Life Sciences Limited.
(2019
sales of 42.45 million Australian Dollars [US$25.78 million]
),
AFT Pharmaceuticals Ltd
of NEW ZEALAND
(85.13 million New Zealand Dollars [US$50.28 million]
of which 59%
was Australia), and
Palla Pharma Ltd
(54.84 million Australian Dollars [US$33.30 million]
of which 85%
was Norway).
Sales Analysis.
Probiotec Limited reported sales of A$79.09 million (US$48.02 million)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 4.4%
versus 2018, when the company's sales were A$75.72 million.